Monarch Capital Management’s Elevance Health ELV Stock Holding History

Monarch Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$446K	Hold	1,153	–	–	0.1%	107
2026 Q1	$338K	Hold	1,153	–	–	0.08%	110
2025 Q4	$404K	Hold	1,153	–	–	0.1%	105
2025 Q3	$373K	Hold	1,153	–	–	0.09%	107
2025 Q2	$448K	Hold	1,153	–	–	0.12%	96
2025 Q1	$502K	Hold	1,153	–	–	0.14%	90
2024 Q4	$425K	Hold	1,153	–	–	0.12%	94
2024 Q3	$600K	Hold	1,153	–	–	0.16%	83
2024 Q2	$625K	Hold	1,153	–	–	0.18%	81
2024 Q1	$598K	Sell	1,153 -55	-5%	-$27.4K	0.17%	83
2023 Q4	$570K	Sell	1,208 -200	-14%	-$92.5K	0.17%	82
2023 Q3	$613K	Sell	1,408 -68	-5%	-$30.8K	0.2%	73
2023 Q2	$656K	Hold	1,476	–	–	0.2%	75
2023 Q1	$679K	Sell	1,476 -195	-12%	-$92.8K	0.21%	73
2022 Q4	$857K	Sell	1,671 -100	-6%	-$50.8K	0.26%	68
2022 Q3	$804K	Hold	1,771	–	–	0.26%	68
2022 Q2	$855K	Hold	1,771	–	–	0.25%	69
2022 Q1	$870K	Hold	1,771	–	–	0.23%	72
2021 Q4	$821K	Hold	1,771	–	–	0.21%	72
2021 Q3	$660K	Buy	1,771 +16	+0.9%	+$6.08K	0.18%	79
2021 Q2	$670K	Hold	1,755	–	–	0.19%	77
2021 Q1	$630K	Hold	1,755	–	–	0.19%	78
2020 Q4	$564K	Sell	1,755 -205	-10%	-$62.9K	0.18%	79
2020 Q3	$526K	Hold	1,960	–	–	0.18%	78
2020 Q2	$515K	Hold	1,960	–	–	0.19%	75
2020 Q1	$445K	Hold	1,960	–	–	0.18%	74
2019 Q4	$592K	Hold	1,960	–	–	0.19%	70
2019 Q3	$471K	Hold	1,960	–	–	0.16%	73
2019 Q2	$553K	Hold	1,960	–	–	0.2%	71
2019 Q1	$562K	Hold	1,960	–	–	0.2%	71
2018 Q4	$515K	Hold	1,960	–	–	0.21%	70
2018 Q3	$537K	Hold	1,960	–	–	0.19%	72
2018 Q2	$467K	Hold	1,960	–	–	0.18%	73
2018 Q1	$431K	Hold	1,960	–	–	0.17%	72
2017 Q4	$441K	Hold	1,960	–	–	0.16%	71
2017 Q3	$372K	Hold	1,960	–	–	0.14%	76
2017 Q2	$369K	Hold	1,960	–	–	0.14%	76
2017 Q1	$324K	Hold	1,960	–	–	0.12%	81
2016 Q4	$282K	Hold	1,960	–	–	0.11%	85
2016 Q3	$246K	Hold	1,960	–	–	0.09%	88
2016 Q2	$257K	Hold	1,960	–	–	0.1%	88
2016 Q1	$272K	Hold	1,960	–	–	0.1%	88
2015 Q4	$273K	Hold	1,960	–	–	0.1%	86
2015 Q3	$274K	Hold	1,960	–	–	0.11%	88
2015 Q2	$322K	Hold	1,960	–	–	0.12%	84
2015 Q1	$303K	Hold	1,960	–	–	0.11%	87
2014 Q4	$246K	Hold	1,960	–	–	0.09%	88
2014 Q3	$234K	Hold	1,960	–	–	0.09%	88
2014 Q2	$211K	Buy	+1,960	New	+$202K	0.08%	89

Other funds holding ELV

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Monarch Capital Management's ELV Position: Q2 2026 in Review

Monarch Capital Management held its Elevance Health (ELV) position steady in Q2 2026 at 1,153 shares worth $446K. The position accounts for 0.1% of the portfolio, ranked #107.

Monarch Capital Management first reported a position in ELV in Q2 2014 and has held it in 49 quarters since. The position peaked at $870K in Q1 2022. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Monarch Capital Management held 1,153 shares of Elevance Health worth $446K as of Q2 2026.
Monarch Capital Management left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 0.1% of Monarch Capital Management's portfolio in Q2 2026, its #107 holding.
Monarch Capital Management first reported a position in Elevance Health in Q2 2014 and has held it in 49 quarters since.
Monarch Capital Management's Elevance Health position peaked at $870K in Q1 2022.
637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.